Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Omeprazole and Acidic Beverage on Sotorasib PK
NCT05497557Phase 1Completed
- Sponsor
- Amgen
- Start
- Jul 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sotorasib in Non-small cell lung cancer (NSCLC), sponsored by Amgen. Primary endpoints: Maximum Observed Plasma Concentration at 48 hours, Area Under the Concentration-time Curve From Time 0 Extrapolated to Infinity at 48 hours and 1 more. Started Jul 2022; status: completed.
02
Drugs
sotorasib
03
Conditions
Non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05497557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05497557.